Impact of endocrine disrupting chemicals (EDCs) on the predisposition of cancer and polycystic ovary syndrome (PCOS): A Note
Abstract
Endocrine Disrupting Chemicals (EDCs) or Endocrine Disruptors are unique assemblage or cluster of emerging pollutants as they affect the synthesis, release and transport of hormones. EDCs have been associated with a diverse array of health issues and diseases. EDCs can alter the endocrine system and are involved in carcinogenesis and inducing poly-cystic ovary syndrome (PCOS). The objective of this article is to furnish an outline of research on environmental aspects of EDCs and their effects on human health specially on cancer and PCOS based on evidence from animal and human studies. EDCs include natural compounds such as phytoestrogens and various synthetic chemicals which are utilized by the chemical, agriculture, cosmetic and food industries. Several EDCs may work as carcinogens and causes initiation and advancement of cancer. Uterine and ovarian cancers of female have been associated with exposure to EDC. Bisphenol-A (BPA), an EDC which is found in plastic bottles, household materials, canned food, waste water, beverage containers and thermal paper, can increase risk of breast cancer. Even low levels of BPA exposure may poses threat of prostate cancer in men. Testicular cancer and thyroid cancer could be influenced by EDCs. Comprehensive studies have been conducted by many researchers in the light of toxicity pattern of EDC that render interpretation of impact of EDCs on development of cancer and PCOS inducing capacity in female reproductive system.
Keywords: Endocrine disrupting chemicals; EDC; Cancer; Endocrine Disruptor, Poly-Cystic Ovary Syndrome; PCOS
Keywords:
Endocrine disrupting chemicals, EDC, Cancer, Endocrine Disruptor, Poly-Cystic Ovary Syndrome, PCOSDOI
https://doi.org/10.22270/jddt.v12i5.5582References
Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT. Executive summary to EDC-2: the endocrine Society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev 2015; 36(6):593–602.
Hass U, Christiansen S, Andersen MD, Abildgaard Rosenberg S, Egebjerg K Mandrup, Brandt S, Nikolov NG, Holbech H, Ebsen Morthorst J. List of Endocrine Disrupting Chemicals. Prepared by the Danish Centre on Endocrine Disrupters for the Danish Environmental Protection Agency. Copenhagen, Denmark: Danish Environmental Protection Agency. 2018.
Combarnous Y, Nguyen TMD. Comparative overview of the mechanisms of action of hormones and endocrine disruptor compounds. Toxics 2019; 7(1): 5.
Casals-Casas C, Desvergne, B. Endocrine disruptors: From endocrine to metabolic disruption. Annu Rev Physiol 2011; 73: 135–162.
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: an Endocrine Society scientific statement, Endocr Rev 2009; 30(4):293–342.
Gavrilescu M, Demnerová K, Aamand J, Agathos S, Fava F. Emerging pollutants in the environment: present and future challenges in biomonitoring, ecological risks and bioremediation. N Biotechnol 2015; 32(1):147-156.
Koklesova L, Liskova A, Samec M, Qaradakhi T, Zulli A, Smejkal K, Kajo K, Jakubikova J, Behzadi P, Pec M, Zubor P, Biringer K, Kwon TK, Büsselberg D, Sarria GR, Giordano FA, Golubnitschaja O, Kubatka P. Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine. EPMA J 2020; 11:261–287.
Prakash O, Kumar A, Kumar P, Ajeet A. Anticancer Potential of Plants and Natural Products: A Review. Am J Pharmacol Sci 2013; 1(6):104–115.
Soto AM, Sonnenschein C. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat Rev Endocrinol 2010; 6(7):363-370.
Albini A, Rosano C, Angelini G, Amaro A, Esposito AI, Maramotti S, Noonan DM, Pfeffer U. Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors. Curr Med Chem 2014; 21(9):1129–1145.
Dumitrascu MC, Mares C, Petca RC, Sandru F, Popescu RI, Mehedintu C, Petca A. Carcinogenic effects of bisphenol A in breast and ovarian cancers. Oncol Lett 2020; 20(6):282.
Ma R, Sassoon DA. PCBs exert an estrogenic effect through repression of the Wnt7a signaling pathway in the female reproductive tract. Environ Health Perspect 2006; 114(6):898–904.
Shafei A, Ramzy MM, Hegazy AI, Husseny AK, El-Hadary UG, Taha MM, Mosa AA. The molecular mechanisms of action of the endocrine disrupting chemical bisphenol A in the development of cancer. Gene 2018;647:235-243.
Pellerin E, Caneparo C, Chabaud S, Bolduc S, Pelletier M. Endocrine-disrupting effects of bisphenols on urological cancers. Environ Res 2021; 195:110485.
Alsen M, Sinclair C, Cooke P, Ziadkhanpour K, Genden E, van Gerwen M. Endocrine Disrupting Chemicals and Thyroid Cancer: An Overview. Toxics 2021; 9(1):14.
Rachoń D. Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients. Rev Endocr Metab Disord 2015; 16(4):359-364.
Scsukova S, Rollerova E, Bujnakova Mlynarcikova A. Impact of endocrine disrupting chemicals on onset and development of female reproductive disorders and hormone-related cancer. Reprod Biol 2016; 16(4):243-254.
Fernández M, Bourguignon N, Luxlantos V, Libertun C. Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Environ Health Perspect 2010; 118(9):1217-1222.
Newbold RR, Jefferson WN, Padilla-Banks E. Prenatal exposure to bisphenol A at environmentally relevant doses adversely affects themurine female reproductive tract later in life. Environ Health Perspect 2009; 117(6):879-885.
Machtinger R, Orvieto R. Bisphenol A, oocyte maturation, implantation, and IVF outcome: review of animal and human data. Reprod Biomed Online 2014; 29(4):404-410.
Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol 2013; 42:132-155.
Peretz J, Vrooman L, Ricke WA, Hunt PA, Ehrlich S, Hauser R, Padmanabhan V, Taylor HS, Swan SH, VandeVoort CA, Flaws JA. Bisphenol A and reproductive health: update of experimental and human evidence, 2007–2013. Environ Health Perspect 2014; 122(8): 775–786.
Tomza-Marciniak A, Stępkowska P, Kuba J, Pilarczyk B. Effect of bisphenol A on reproductive processes: A review of in vitro, in vivo and epidemiological studies. J Appl Toxicol 2018; 38(1):51–80.
Caserta D, Di Segni N, Mallozzi M, Giovanale V, Mantovani A, Marci R, Moscarini M. Bisphenol A and the female reproductive tract: an overview of recent laboratory evidence and epidemiological studies. Reprod Biol Endocrinol 2014; 12:37.
Shi J, Liu C, Chen M, Yan J, Wang C, Zuo Z, He C. The interference effects of bisphenol A on the synthesis of steroid hormones in human ovarian granulosa cells. Environ Toxicol 2021; 36(4):665–674.
Hu Y, Wen S, Yuan D, Peng L, Zeng R, Yang Z, Liu Q, Xu L, Kang D. The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol 2018; 34(5):370-377.
Rutkowska A, Rachoń D. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS). Gynecol Endocrinol 2014; 30(4): 260–265.
Barrett ES, Sobolewski M. Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role? Semin Reprod Med 2014; 32(3):166-176.
Kechagias KS, Semertzidou A, Athanasiou A, Paraskevaidi M, Kyrgiou M. Bisphenol-A and polycystic ovary syndrome: a review of the literature. Rev Environ Health 2020; 35(4):323–331.
Petta S, Ciresi A, Bianco J, Geraci V, Boemi R, Galvano L, Magliozzo F, Merlino G, Craxì A, Giordano C. Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS. PLoS ONE 2017; 12(11):e0186136.
Wang T, Li M, Chen B, Xu M, Xu Y, Huang Y, Lu J, Chen Y, Wang W, Li X, Liu Y, Bi Y, Lai S, Ning G. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 2012; 97(2):E223–E227.
Yang Z, Shi J, Guo Z, Chen M, Wang C, He C, Zuo Z. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats. Chemosphere. 2019; 231:151-160.
Kandaraki E, Chatzigeorgiou A, Livadas S, Palioura E, Economou F, Koutsilieris M, Palimeri S, Panidis D, Diamanti-Kandarakis E. Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS. J Clin Endocrinol Metab 2011; 96(3):E480–E484.
Hossein Rashidi B, Amanlou M, Behrouzi Lak T, Ghazizadeh M, Haghollahi F, Bagheri M, Eslami B. The Association Between Bisphenol A and Polycystic Ovarian Syndrome: A Case-Control Study. Acta Med Iran 2018; 55(12):759-764.
Akin L, Kendirci M, Narin F, Kurtoglu S, Saraymen R, Kondolot M. Koçak S, Elmalı F. The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls. Acta Paediatr 2015; 104(4): e171-e177.
Vagi SJ, Azziz-Baumgartner E, Sjödin A, Calafat AM, Dumesic D, Gonzalez L. Kato K, Silva MJ, Ye X, Azziz R. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study. BMC Endocr Disord 2014; 14:86.
Jurewicz J, Majewska J, Berg A, Owczarek K, Zajdel R, Kaleta D, Wasik A, Rachoń D. Serum bisphenol A analogues in women diagnosed with the polycystic ovary syndrome – is there an association? Environmental Pollution 2021; 272:115962.
Acevedo N, Davis B, Schaeberle CM, Sonnenschein C, Soto AM. Perinatally administered bisphenol a as a potential mammary gland carcinogen in rats. Environ Health Perspect 2013; 121(9):1040–1046.
Weber Lozada K, Keri RA. Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer. Biol Reprod 2011; 85(3):490–497.
Tarapore P, Ying J, Ouyang B, Burke B, Bracken B, Ho S-M. Exposure to bisphenol A correlates with early-onset prostate cancer and promotes centrosome amplification and anchorage independent growth in vitro. PLoS ONE 2014; 9(3):e90332.
Caballero-Gallardo K, Olivero-Verbel J, Freeman JL. Toxicogenomics to Evaluate Endocrine Disrupting Effects of Environmental Chemicals Using the Zebrafish Model. Curr Genomics 2016; 17(6):515-527.
Juliano C, Magrini GA. Cosmetic Ingredients as Emerging Pollutants of Environmental and Health Concern. A Mini-Review. Cosmetics 2017; 4(2):11.
Timms BG, Howdeshell KL, Barton L, Bradley S, Richter CA, vom Saal FS. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 2005; 102(19):7014-7019.
Timms BG, Peterson RE, vom Saal FS. 2,3,7,8-tetrachlorodibenzo-p-dioxin interacts with endogenous estradiol to disrupt prostate gland morphogenesis in male rat fetuses. Toxicol Sci 2002; 67(2):264-274.
Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, Iguchi T, Juul A, McLachlan JA, Schwartz J, Skakkebaek N, Soto AM, Swan S, Walker C, Woodruff TK, Woodruff TJ, Giudice LC, Guillette LJ Jr. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril 2008; 90(4):911-940.
Rachoń D, Teede H. Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options. Mol Cell Endocrinol 2010; 316(2):172-179.
Carmina E. Polycystic ovary syndrome: metabolic consequences and long-term management. Scand J Clin Lab Invest 2014; 74(sup244):23-26.
Papadakis G, Kandaraki E, Papalou O, Vryonidou A, Diamanti-Kandarakis E. Is cardiovascular risk in women with PCOS a real risk? Current insights. Minerva Endocrinologica 2017; 42(4):340-355.
Milanović M, Milošević N, Sudji J, Stojanoski S, Atanacković Krstonošić M, Bjelica A, Milić N, Medić Stojanoska M. Can environmental pollutant bisphenol A increase metabolic risk in polycystic ovary syndrome? Clin Chim Acta 2020; 507:257-263.
Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity, Clin Chim Acta 2020; 502:214–221.
Calcaterra V, Verduci E, Cena H, Magenes VC, Todisco CF, Tenuta E, Gregorio C, De Giuseppe R, Bosetti A, Di Profio E, Zuccotti G. Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrients 2021; 13(6):1848.
Carreau AM and Baillargeon JP. PCOS in Adolescence and Type 2 Diabetes. Curr Diab Rep 2015; 15:564.
Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism 2019; 92:108–120.
Neff AM, Flaws JA. The effects of plasticizers on the ovary. Curr Opin Endocr Metab Res 2021; 18:35-47.
Axelstad M, Hass U, Scholze M, Christiansen S, Kortenkamp A, Boberg J. EDC IMPACT: reduced sperm counts in rats exposed to human relevant mixtures of endocrine disrupters. Endocr Connect 2018; 7(1):139–148.
Johansson HKL, Svingen T, Fowler PA, Vinggaard AM, Boberg J. Environmental influences on ovarian dysgenesis — developmental windows sensitive to chemical exposures. Nat Rev Endocrinol 2017; 13:400–414.
Skakkebaek NE. A brief review of the link between environment and male reproductive health: lessons from studies of testicular germ cell cancer. Horm Res Paediatr 2016; 86(4):240–246.
Amano I, Takatsuru Y, Khairinisa MA, Kokubo M, Haijima A, Koibuchi N. Effects of mild perinatal hypothyroidism on cognitive function of adult male offspring. Endocrinol 2018; 159(4):1910–1921.
Ghassabian A, Trasande L. Disruption in thyroid signaling pathway: a mechanism for the effect of endocrine-disrupting chemicals on child neurodevelopment. Front Endocrinol 2018; 9: 204.
Jefferson WN, Kinyamu HK, Wang T, Miranda AX, Padilla-Banks E, Suen AA, Williams CJ. Widespread enhancer activation via ERα mediates estrogen response in vivo during uterine development. Nucleic Acids Res 2018; 46(11):5487–5503.
Alonso-Magdalena P, Vieira E, Soriano S, Menes L, Burks D, Quesada I, Nadal A. Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ. Health Perspect 2010; 118(9):1243–1250.
Cano-Sancho G, Salmon AG, La Merrill MA. Association between exposure to p,p’-DDT and its metabolite p,p’-DDE with obesity: integrated systematic review and meta-analysis. Environ Health Perspect 2017; 125(9):096002.
Heindel JJ, Skalla LA, Joubert BR, Dilworth CH, Gray KA. Review of developmental origins of health and disease publications in environmental epidemiology. Reprod Toxicol 2017; 68: 34–48.
Sifakis S, Androutsopoulos VP, Tsatsakis, AM, Spandidos DA. Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems. Environ Toxicol Pharmacol 2017; 51:56–70.
Giulivo M, Lopez de Alda M, Capri E, Barceló D. Human exposure to endocrine disrupting compounds: their role in reproductive systems, metabolic syndrome and breast cancer. A review. Environ Res 2016; 151:251–264.
Lee H-R, Jeung E-B, Cho M-H, Kim T-H, Leung PCK, Cho K-C. Molecular mechanism(s) of endocrine disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors. J Cell Mol Med 2013; 17(1):1–11.
Eve L, Fervers B, Le Romancer M, Etienne-Selloum N. Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer. Int J Mol Sci 2020; 21(23):9139.
Adegoke EO, Rahman MS, Park YJ, Kim YJ, Pang MG. Endocrine-Disrupting Chemicals and Infectious Diseases: From Endocrine Disruption to Immunosuppression. Int J Mol Sci 2021; 22(8):3939.
Park MA, Hwang KA, Choi KC. Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property?. Lab Anim Res 2011; 27(4):265-273.
Houston TJ, Ghosh R. Untangling the association between environmental endocrine disruptive chemicals and the etiology of male genitourinary cancers. Biochem Pharmacol 2020; 172:113743.
Schug, TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011; 127(3-5):204–215.
Nowak K, Jabłońska E, Ratajczak-Wrona W. Immunomodulatory effects of synthetic endocrine disrupting chemicals on the development and functions of human immune cells. Environ Int 2019; 125:350–364.
Rahman, M.S, Kwon WS, Karmakar PC, Yoon SJ, Ryu BY, Pang MG. Gestational Exposure to Bisphenol-A Affects the Function and Proteome Profile of F1 Spermatozoa in Adult Mice. Environ Health Perspect 2017; 125(2):238–245.
Kassotis CD, Vandenberg LN, Demeneix BA, Porta M, Slama R, Trasande L. Endocrine-disrupting chemicals: economic, regulatory, and policy implications. Lancet Diabetes Endocrinol 2020; 8(8):719-730.
Kahn LG, Philippat C, Nakayama SF, Slama R, Trasande L. Endocrine-disrupting chemicals: implications for human health. Lancet Diabetes Endocrinol 2020; 8(8):703-718.
Published
Abstract Display: 650 
PDF Downloads: 660 PDF Downloads: 98 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.